ARA-290
Cibinetide
Mechanism
Agonista selectivo del receptor de reparación innato (IRR) que reduce la inflamación y promueve la reparación de tejidos.
Half-Life
Short
Administration
Technical Protocol
ARA-290 Guide
ARA-290 is primarily researched for small fiber neuropathy and inflammatory conditions.
Peer-Reviewed Citations
ARA 290, a peptide derived from erythropoietin, for the treatment of sarcoidosis
Dahan A, et al. • Mol Med (2013)
Access ResearchFrequently Asked Questions
What is ARA-290?
Un péptido derivado de la eritropoyetina (EPO) que ataca la inflamación y el dolor nervioso.
How does ARA-290 work?
Agonista selectivo del receptor de reparación innato (IRR) que reduce la inflamación y promueve la reparación de tejidos.
What is the typical dosage of ARA-290 in research?
The typical research dosage of ARA-290 is 2 mg (range: 1-4 mg daily). Common administration routes include Subcutaneous.
How should ARA-290 be stored?
Store at 2-8°C, protect from light
Source ARA-290 for Your Research
Third-party tested, EU-shipped, certificate of analysis included. High-purity ARA-290 available from our verified research partner.
Shop ARA-290Related Healing Peptides
BPC-157
A 15 amino acid peptide derived from gastric BPC protein. Studied for regenerative properties and tissue healing.
healingTB-500
Natural 43 amino acid peptide involved in cell repair and wound healing.
healingKPV
A small but powerful peptide studied for its anti-inflammatory effects, particularly in the gut.
healingVIP
A neuropeptide with powerful anti-inflammatory and vascular effects.